|
|
||||||||
IMMUNOLOGY, HEALTH, AND DISEASE |



* École Nationale Vétérinaire de Toulouse, Mycotoxicology Unit, 23 chemin des Capelles, BP 87614, 31076 Toulouse Cedex 3, France; and
Arvalis-Institut du Végétal, 21 chemin de Pau, 64121 Montardon, France
1 Corresponding author: p.guerre{at}envt.fr
| ABSTRACT |
|---|
|
|
|---|
Key Words: fumonisin turkey toxicity mycotoxin corn
| INTRODUCTION |
|---|
|
|
|---|
Previous studies conducted in birds showed that high exposure to fumonisins (100 mg of fumonisins/kg of feed and more) reduces performance and is responsible for alterations in serum constituents and enzyme activities and for hepatitis or hepatic hyperplasia in broilers, turkeys, quails, and ducks (Brown et al., 1992; Ledoux et al., 1992, 1996; Weibking et al., 1993a,b, 1995; Espada et al., 1994, 1997; Bermudez et al., 1995, 1997; Kubena et al., 1995a, 1997a, Kubena et al., b; Henry et al., 2000; Bailly et al., 2001; Tran et al., 2003, 2005; Tardieu et al., 2004). These effects are associated with altered sphingolipid biosynthesis and an increased sphinganine to sphingosine (Sa/So) ratio (Weibking et al., 1993a; Ledoux et al., 1996; Henry et al., 2000; Bailly et al., 2001; Broomhead et al., 2002; Tran et al., 2003, 2006; Tardieu et al., 2004, 2006). Although subacute toxicity of FB1 has frequently been investigated in avian species, the chronic effects of FB1 are less well understood. Previous studies conducted in 14- and 18-wk-old turkeys demonstrated that, respectively, 50 and 75 mg of FB1/kg of feed are detrimental to animal performance (Bermudez et al., 1996; Broomhead et al., 1998, 2002). In contrast, FB1 had no effect on BW gain in broilers fed 50 mg of FB1/kg at marketing age (7 wk; Broomhead et al., 2002) or in laying hens fed 200 mg of FB1/kg for 420 d (Kubena et al., 1999). Surprisingly, in ducks, 10 wk of exposure to fumonisins seems to be better tolerated than 1 wk of exposure (Tardieu et al., 2006). Moreover, the effects of fumonisins on protein, cholesterol, alanine aminotransferase, and lactate dehydrogenase (LDH) in plasma were shown to be reversible during chronic exposure, and the increase in free Sa and the Sa/So ratio in liver and kidneys was less pronounced after 10 wk of exposure to the toxin than after 1 wk (Tardieu et al., 2006; Tran et al., 2006).
The objective of the present study was to investigate the chronic effects of feeding different levels of FB1 to 1- to 10-wk-old turkeys. Three levels of FB1 were investigated, the highest being the maximum recommended by the European Union (2006) for fumonisins in avian feed. Response variables used to evaluate toxicity included body weight, feed consumption, relative organ weights, serum chemistry, histopathology, and serum, liver, and kidney Sa/So ratios.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Preparation of Feed
The feed was formulated and manufactured at the experimental station of Boigneville (ARVALIS–Institut du végétal, Boigneville, France) according to usual practices to provide equal protein contents and energy intake, as well as to meet amino acid (Lys, sulphur amino acids, and Trp) and mineral requirements. A starter diet and 2 growth diets were prepared in the form of a mixture of raw materials not contaminated by mycotoxins and a mixture including different percentages (0 to 20%) of a batch of corn contaminated by fumonisins [FB1 + fumonisin B2 (FB2) = 117 mg/kg] and of a batch of corn of the same origin that was not contaminated (12 to 32%). The levels of contamination of the final feed were as follows: 0, 5, 10, and 20 mg of FB1 + FB2/kg. The absence of other mycotoxins was confirmed by chromatography, ELISA, or both (concentrations of aflatoxin B1, ochratoxine A, zearalenone, deoxynivalenol, and T2 toxin, respectively lower than 10, 10, 50, 250, and 50 µg/kg).
Animals
Three hundred 1-d-old male turkeys of the BUT 9 strain (Sicamen, Volnay, France) were placed in cages in groups of 2 at the experimental station of Pouline (ARVALIS–Institut du végétal, Pouline, Villerable, France) with free access to feed. The noncontaminated starter diet was distributed to all the turkeys for 1 wk. At the end of this phase of adaptation, feed consumption was measured and 150 turkey poults were divided into 4 batches of 36 animals on the basis of their live weight and placed in individual cages. The 6 remaining turkeys were used for the first sample collection. The turkeys were weighed, and the feed consumption was measured on d 14, 21, 28, 42, 56, and 70.
Sample Collection
Feed was removed 8 h before killing. Six animals were taken at the end of the phase of adaptation, and 6 animals per batch were taken randomly at d 14, 21, 28, 42, 56, and 70, weighed, and killed to check for a possible pathology. Blood samples were collected in dry tubes before killing and centrifuged for 15 min at 3,000 x g after coagulation. The serum was removed and stored at –0°C until use. The different organs were separated and weighed to measure the possible effect of fumonisins on tissue mass. Ten grams each of liver and kidney were removed and stored at –20°C until analysis. Ten grams of each organ was also placed in a vessel containing formaldehyde (10% wt/vol), then stored at ambient temperature until microscopic analysis.
Biochemistry
Serum concentrations of alanine aminotransferase (EC 2.6.1.2
[EC]
), aspartate aminotransferase (EC 2.6.1.1
[EC]
), and lactate dehydrogenase (EC 1.1.1.27
[EC]
) were analyzed with a Hitachi 717 clinical chemistry analyzer (Hitachi, Tokyo, Japan) according to international guidelines; values were expressed in units per liter. Cholesterol was measured by enzymatic reaction, and protein was determined using the Biuret method modified according to the recommendations of Hitachi.
Sphingosine and Sphinganine Determination
Free So and free Sa were determined in serum, liver, and kidney by HPLC according to Riley et al. (1994a). Briefly, 0.2 nmol of C20 Sa (BioValley S. A., Marne la Vallée, France) was added to 100 µL of serum or tissue homogenates. Lipids were extracted with alkaline methanolic-chloroform and further hydrolyzed to liberate free Sa and So. The chloroform phase was then washed twice with alkaline water. Samples were dried and suspended in 20 µL of methanol. Extracts were derived with orthophtaldialdehyde and sonicated for 10 min before injection. Sphinganine, So, and C20 Sa concentrations were determined by HPLC using an ICS M2200 solvent delivery module (ICS, Toulouse, France) connected with a programmable fluorescence detector (FD-500 Shimazu, Kyoto, Japan). Operating conditions were analytical Radial-Pak cartridge packed with Nova-Pak C18 and a C18 precolumn filter (Waters Associates Inc., Milford, MA), liquid phase: methanol-water (90:10), flow rate: 1.25 mL/min, excitation wavelength: 335 nm, emission wavelength: 440 nm. Every day a standard solution containing known amounts of So, Sa, and C20 Sa mixture was run to verify the column performance and stability of the orthophtaldialdehyde reagent. Mean retention times were 12, 17, and 29 min for So, Sa, and C20 Sa, respectively.
All other chemicals and reagents were of the highest grade available. They were purchased from Scharlau (Scharlau Chimie S.A., Barcelona, Spain) and Sigma Chemical Co. (Sigma, Saint Quentin Fallavier, France). In all studies, distilled deionized water was used.
Statistical Analysis
Data for all response variables were reported as means ± SD and subjected to 1-way ANOVA. When significant differences were obtained, differences between means were determined by the Tukeys test.
| RESULTS |
|---|
|
|
|---|
|
|
Serum Biochemistry
The effect of fumonisins on various serum biochemical parameters of turkeys during exposure to fumonisins are presented in Table 2
. No effect was observed on protein and cholesterol concentrations whatever the day of exposure. Concerning enzyme activities, although a moderate increase in LDH activity occurred in turkeys fed 20 mg of fumonisins/kg of feed from d 21 to 56, this increase was not significant. Moreover, alanine aminotransferase and aspartate aminotransferase activities remained constant throughout the study.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In agreement with the lack of effect on performances, we observed no effect on the biochemical parameters used to investigate liver damage whatever the level of fumonisins in the feed. This result agrees with previous data obtained in ducks, which showed that a level of FB1 in feed equal to 32 mg/kg was necessary to increase cholesterol, LDH, and alanine aminotransferase concentrations in serum, whereas 128 mg/kg was necessary to increase proteins and aspartate aminotransferase (Tran et al., 2006). Finally, the lack of effect of fumonisins on biochemistry in turkeys is not surprising because previous studies in turkeys demonstrated that effects on biochemistry were only obtained at levels of exposure higher than that which had an effect on performance (Kubena et al., 1995a,b, 1997a; Ledoux et al., 1996).
Interestingly, although no sign of toxicity and no effect on biochemistry and tissue weight were observed during fumonisins exposure in this study, a marked increase in the Sa/So ratio was obtained in liver and kidney. The magnitude of the increase in the Sa/So ratio at the end of the study is of the same level as in our previously published study, which used fumonisins obtained from culture material of F. verticillioides at the end of the exposure (Broomhead et al., 2002). Interestingly, we demonstrate for the first time in turkeys that a significant increase in Sa/So can be obtained a few days after the beginning of the exposure to fumonisins at a level of 20 mg of FB1 + FB2/kg of feed. This confirms that disruption of sphingolipid metabolism is an early event when animals are exposed to fumonisins. It precedes signs of toxicity, in agreement with data obtained in ducks (Tran et al., 2003, 2006) and mammals (Voss et al., 1999; van der Westhuizen et al., 2001; Zomborszky-Kovacs et al., 2002). However, the increase in the Sa/So ratio in liver and kidney appeared to be less pronounced than that obtained during fumonisin exposure in ducks (Tardieu et al., 2006). This difference confirms that turkeys are more resistant to fumonisins than ducks. In turkeys, the kidney and liver seem to have the same sensitivity to the disruption of sphingolipid metabolism by fumonisins, whereas kidneys were more sensitive in ducks (Tardieu et al., 2006), rats (Riley et al., 1994b; Bondy et al., 1996), and rabbits (LaBorde et al., 1997). In the liver, the increase in the Sa/So ratio results primarily from an increase in Sa concentrations (Figures 3
and 4
). By contrast, in the kidney, So concentrations are also slightly higher, especially in turkeys exposed to 20 mg of fumonisins/kg of feed. The latter effect on So in the kidney is in disagreement with what was previously reported in duck, with So remaining nearly constant throughout the exposure period (Tardieu et al., 2006). It confirms the importance of the joint interpretation of the concentrations of Sa and the Sa/So ratio in the determination of exposure to fumonisins. Finally, increases in the Sa/So ratio occur before other signs of toxicity in all avian species in which it has been investigated (Weibking et al., 1993b, 1994; Ledoux et al., 1996; Henry et al., 2000; Bailly et al., 2001; Broomhead et al., 2002; Tran et al., 2003). To date, the consequences of a disruption of sphingolipid metabolism on avian health are unknown because it is not known whether these disruptions have a technological or a gustative impact on meat prepared from exposed animals.
In conclusion, the distribution of a feed containing fumonisins at levels of 5, 10, and 20 mg FB1 + FB2/kg over a 63-d period had no effect on performance or on serum biochemistry. This study confirms that the level of fumonisins in avian feed of 20 mg of FB1 + FB2/kg recommended by the European Commission can be considered as safe for these animals. Nevertheless, the lack of effect of fumonisins on performance and on biochemistry does not mean that these mycotoxins have no effect on turkeys. Indeed, a disruption of sphingolipid metabolism was observed at a level of FB1 + FB2 in feed equal or higher to 10 mg/kg. Finally, the Sa/So ratio appeared to be the best biomarkers of fumonisin exposure in turkeys.
| ACKNOWLEDGMENTS |
|---|
The results presented were obtained thanks to the financial participation of Maïsadour, Syngenta Seeds, the Midi-Pyrenées Region, and the French Ministry of Research within the framework of the RARE program Fusariotoxines 2003–2006.
Received for publication February 27, 2007. Accepted for publication May 26, 2007.
| REFERENCES |
|---|
|
|
|---|
Bermudez, A. J., D. R. Ledoux, and G. E. Rottinghaus. 1995. Effects of Fusarium moniliforme culture material containing known levels of fumonisin B1 in ducklings. Avian Dis. 39:879–886.[ISI][Medline]
Bermudez, A. J., D. R. Ledoux, G. E. Rottinghaus, and G. A. Bennett. 1997. The individual and combined effects of the Fusarium mycotoxins moniliformin and fumonisin B1 in turkeys. Avian Dis. 41:304–311.[ISI][Medline]
Bermudez, A. J., D. R. Ledoux, J. R. Turk, and G. E. Rottinghaus. 1996. The chronic effects of Fusarium moniliforme culture material, containing known levels of fumonisin B1, in turkeys. Avian Dis. 40:231–235.[ISI][Medline]
Bondy, G., M. Barker, R. Mueller, S. Fernie, J. D. Miller, C. Armstrong, S. L. Hierlihy, P. Rowsell, and C. Suzuki. 1996. Fumonisin B1 toxicity in male Sprague-Dawley rats. Adv. Exp. Med. Biol. 392:251–264.[Medline]
Broomhead, J. N., D. R. Ledoux, A. J. Bermudez, and G. E. Rottinghaus. 1998. Effect of fumonisin B1 in broilers and turkeys fed dietary treatments to market age. UMC Anim. Sci. Departmental Rep.:107–110.
Broomhead, J. N., D. R. Ledoux, A. J. Bermudez, and G. E. Rottinghaus. 2002. Chronic effects of fumonisin B1 in broilers and turkeys fed dietary treatments to market age. Poult. Sci. 81:56–61.
Brown, T. P., G. E. Rottinghaus, and M. E. Williams. 1992. Fumonisin mycotoxicosis in broilers: Performance and pathology. Avian Dis. 36:450–454.[ISI][Medline]
Espada, Y., R. Ruiz de Gopegui, C. Cuadradas, and F. J. Cabanes. 1994. Fumonisin mycotoxicosis in broilers. Weights and serum chemistry modifications. Avian Dis. 38:454–460.[ISI][Medline]
Espada, Y., R. Ruiz de Gopegui, C. Cuadradas, and F. J. Cabanes. 1997. Fumonisin mycotoxicosis in broilers: Plasma proteins and coagulation modifications. Avian Dis. 41:73–79.[ISI][Medline]
European Union. 2006. Journal officiel UE, 23/8/2006. L229/7.
Gelderblom, W. C., N. P. Kriek, W. F. Marasas, and P. G. Thiel. 1991. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12:1247–1251.
Henry, M. H., R. D. Wyatt, and O. J. Fletchert. 2000. The toxicity of purified fumonisin B1 in broiler chicks. Poult. Sci. 79:1378–1384.
Howard, P. C., R. M. Eppley, M. E. Stack, A. Warbritton, K. A. Voss, R. J. Lorentzen, R. M. Kovach, and T. J. Bucci. 2001. Fumonisin B1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 109(Suppl. 2):277–282.[ISI][Medline]
Kubena, L. F., T. S. Edrington, R. B. Harvey, S. A. Buckley, T. D. Phillips, G. E. Rottinghaus, and H. H. Casper. 1997b. Individual and combined effects of fumonisin B1 present in Fusarium moniliforme culture material and T-2 toxin or deoxynivalenol in broiler chicks. Poult. Sci. 76:1239–1247.
Kubena, L. F., T. S. Edrington, R. B. Harvey, T. D. Phillips, A. B. Sarr, and G. E. Rottinghaus. 1997a. Individual and combined effects of fumonisin B1 present in Fusarium moniliforme culture material and diacetoxyscirpenol or ochratoxin A in turkey poults. Poult. Sci. 76:256–264.
Kubena, L. F., T. S. Edrington, C. Kamps-Holtzapple, R. B. Harvey, M. H. Elissalde, and G. E. Rottinghaus. 1995a. Effects of feeding fumonisin B1 present in Fusarium moniliforme culture material and aflatoxin singly and in combination to turkey poults. Poult. Sci. 74:1295–1303.[ISI][Medline]
Kubena, L. F., T. S. Edrington, C. Kamps-Holtzapple, R. B. Harvey, M. H. Elissalde, and G. E. Rottinghaus. 1995b. Influence of fumonisin B1, present in Fusarium moniliforme culture material, and T-2 toxin on turkey poults. Poult. Sci. 74:306–313.[ISI][Medline]
Kubena, L. F., R. B. Harvey, S. A. Buckley, R. H. Bailey, and G. E. Rottinghaus. 1999. Effects of long-term feeding of diets containing moniliformin, supplied by Fusarium fujikuroi culture material, and fumonisin, supplied by Fusarium moniliforme culture material, to laying hens. Poult. Sci. 78:1499–1505.
LaBorde, J. B., K. K. Terry, P. C. Howard, J. J. Chen, T. F. Collins, M. E. Shackelford, and D. K. Hansen. 1997. Lack of embryotoxicity of fumonisin B1 in New Zealand white rabbits. Fundam. Appl. Toxicol. 40:120–128.[ISI][Medline]
Ledoux, D. R., A. J. Bermudez, and G. E. Rottinghaus. 1996. Effects of feeding Fusarium moniliforme culture material, containing known levels of fumonisin B1, in the young turkey poult. Poult. Sci. 75:1472–1478.[ISI][Medline]
Ledoux, D. R., T. P. Brown, T. S. Weibking, and G. E. Rottinghaus. 1992. Fumonisin toxicity in broiler chicks. J. Vet. Diagn. Invest. 4:330–333.
Marasas, W. F. 1995. Fumonisins: Their implications for human and animal health. Nat. Toxins 3:193–198.[Medline]
Riley, R. T., D. M. Hinton, W. J. Chamberlain, C. W. Bacon, E. Wang, A. H. Merrill, Jr., and K. A. Voss. 1994b. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: A new mechanism of nephrotoxicity. J. Nutr. 124:594–603.
Riley, R. T., E. Wang, and A. H. Merrill. 1994a. Liquid chromatographic determination of sphinganine and sphingosine: Use of the free sphinganine to sphingosine ratio as a biomarker for consumption of fumonisin. J. AOAC Int. 77:533–540.[ISI]
Tardieu, D., J. D. Bailly, G. Benard, S. T. Tran, and P. Guerre. 2004. FB1 toxicity in ducks during force-feeding. Poult. Sci. 83:1287–1293.
Tardieu, D., S. T. Tran, A. Auvergne, R. Babile, G. Benard, J. D. Bailly, and P. Guerre. 2006. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. Chem. Biol. Interact. 160:51–60.[ISI][Medline]
Tran, S. T., A. Auvergne, G. Benard, J. D. Bailly, D. Tardieu, R. Babilé, and P. Guerre. 2005. Chronic effects of fumonisin B1 on ducks. Poult. Sci. 84:22–28.
Tran, S. T., J. D. Bailly, D. Tardieu, S. Durand, G. Benard, and P. Guerre. 2003. Sphinganine to sphingosine ratio and predictive biochemical markers of fumonisin B1 exposure in ducks. Chem. Biol. Interact. 146:61–72.[ISI][Medline]
Tran, S. T., D. Tardieu, A. Auvergne, J. D. Bailly, R. Babile, S. Durand, G. Benard, and P. Guerre. 2006. Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks. Chem. Biol. Interact. 160:41–50.[ISI][Medline]
van der Westhuizen, L., G. S. Shephard, and D. J. van Schalkwyk. 2001. The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys. Toxicon 39:969–972.[Medline]
Voss, K. A., J. K. Porter, C. W. Bacon, F. I. Meredith, and W. P. Norred. 1999. Fusaric acid and modification of the subchronic toxicity to rats of fumonisins in F. moniliforme culture material. Food Chem. Toxicol. 37:853–861.[ISI][Medline]
Weibking, T. S., D. R. Ledoux, A. J. Bermudez, and G. E. Rottinghaus. 1994. Individual and combined effects of feeding Fusarium moniliforme culture material, containing known levels of fumonisin B1, and aflatoxin B1 in the young turkey poult. Poult. Sci. 73:1517–1525.[ISI][Medline]
Weibking, T., D. R. Ledoux, A. J. Bermudez, J. R. Turk, and G. E. Rottinghaus. 1995. Effects on turkey poults of feeding Fusarium moniliforme M-1325 culture material grown under different environmental conditions. Avian Dis. 39:32–38.[ISI][Medline]
Weibking, T. S., D. R. Ledoux, T. P. Brown, and G. E. Rottinghaus. 1993a. Fumonisin toxicity in turkey poults. J. Vet. Diagn. Invest. 5:75–83.
Weibking, T. S., D. R. Ledoux, A. J. Bermudez, J. R. Turk, G. E. Rottinghaus, E. Wang, and A. H. Merrill Jr. 1993b. Effects of feeding Fusarium moniliforme culture material, containing known levels of fumonisin B1, on the young broiler chick. Poult. Sci. 72:456–466.[ISI][Medline]
WHO. 2002. Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Org. Tech. Rep. Ser. 906:1–62.
Yoshizawa, T., A. Yamashita, and Y. Luo. 1994. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl. Environ. Microbiol. 60:1626–1629.
Zomborszky-Kovacs, M., F. Vetesi, P. Horn, I. Repa, and F. Kovacs. 2002. Effects of prolonged exposure to low-dose fumonisin B1 in pigs. J. Vet. Med. B Infect. Dis. Vet. Public Health 49:197–201.[ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |